350 related articles for article (PubMed ID: 20698841)
1. Perfluorocarbon-based oxygen carriers: review of products and trials.
Castro CI; Briceno JC
Artif Organs; 2010 Aug; 34(8):622-34. PubMed ID: 20698841
[TBL] [Abstract][Full Text] [Related]
2. Perfluorocarbon-based oxygen delivery.
Riess JG
Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):567-80. PubMed ID: 17090429
[TBL] [Abstract][Full Text] [Related]
3. Blood substitutes in surgery.
Burris D
Ann Chir Gynaecol; 2001; 90(2):76-80. PubMed ID: 11459262
[TBL] [Abstract][Full Text] [Related]
4. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.
Kim HW; Greenburg AG
Artif Organs; 2004 Sep; 28(9):813-28. PubMed ID: 15320945
[TBL] [Abstract][Full Text] [Related]
5. Clinical potential of intravenously administered perfluorocarbons.
Habler O; Kleen M; Messmer K
Acta Anaesthesiol Scand Suppl; 1997; 111():256-8. PubMed ID: 9421036
[No Abstract] [Full Text] [Related]
6. Alternative oxygen therapeutics: products, status of clinical trials, and future prospects.
Winslow RM
Curr Hematol Rep; 2003 Nov; 2(6):503-10. PubMed ID: 14561395
[TBL] [Abstract][Full Text] [Related]
7. [Biophysics at the turn of the new millenium: perfluorocarbon media and gas-transporting blood substitutes].
Ivanitskiĭ GR
Biofizika; 2001; 46(1):5-33. PubMed ID: 11236562
[TBL] [Abstract][Full Text] [Related]
8. [Current aspects in red blood cell substitutes].
Wang Y; Pan J; Yu Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):490-4. PubMed ID: 15250164
[TBL] [Abstract][Full Text] [Related]
9. Perfluorinated blood substitutes and artificial oxygen carriers.
Lowe KC
Blood Rev; 1999 Sep; 13(3):171-84. PubMed ID: 10527269
[TBL] [Abstract][Full Text] [Related]
10. Perfluorocarbon-based oxygen carriers: from physics to physiology.
Jägers J; Wrobeln A; Ferenz KB
Pflugers Arch; 2021 Feb; 473(2):139-150. PubMed ID: 33141239
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with Fluosol-DA.
Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Moss GS
Prog Clin Biol Res; 1983; 122():331-42. PubMed ID: 6878375
[TBL] [Abstract][Full Text] [Related]
12. Oxygen therapeutics--current concepts.
Hill SE
Can J Anaesth; 2001 Apr; 48(4 Suppl):S32-40. PubMed ID: 11336435
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic properties of hemoglobin vesicles as a substitute for red blood cells.
Taguchi K; Maruyama T; Otagiri M
Drug Metab Rev; 2011 Aug; 43(3):362-73. PubMed ID: 21428698
[TBL] [Abstract][Full Text] [Related]
14. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery.
Riess JG
Artif Cells Blood Substit Immobil Biotechnol; 2005; 33(1):47-63. PubMed ID: 15768565
[TBL] [Abstract][Full Text] [Related]
15. Oxygen carriers ("blood substitutes").
Topfer LA; Hailey D
Issues Emerg Health Technol; 2001 Jul; (21):1-6. PubMed ID: 11776287
[TBL] [Abstract][Full Text] [Related]
16. Perflubron emulsion (Oxygent(tm)): a temporary intravenous oxygen carrier.
Keipert PE
Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Nov; 36 Suppl 2():S104-6. PubMed ID: 11753711
[No Abstract] [Full Text] [Related]
17. Treatment of severe anaemia with perfluorocarbon blood substitutes: a clinical overview.
Nyberg SL; Cerra FB
Clin Intensive Care; 1991; 2(4):226-32. PubMed ID: 10149096
[No Abstract] [Full Text] [Related]
18. Artificial blood.
Squires JE
Science; 2002 Feb; 295(5557):1002-5. PubMed ID: 11834811
[TBL] [Abstract][Full Text] [Related]
19. [The corrective effect of perfluorocarbon emulsions on the cerebral hemodynamics in craniocerebral trauma].
Krivoshapkin AL; Krivoshapkin AL; Semenycheva TV
Zh Vopr Neirokhir Im N N Burdenko; 1992; (6):17-9. PubMed ID: 1337408
[TBL] [Abstract][Full Text] [Related]
20. New transfusion strategies: red cell substitutes.
Winslow RM
Annu Rev Med; 1999; 50():337-53. PubMed ID: 10073282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
